Pembrolizumab plus axitinib combination and the paradigm change in the treatment of advanced renal cell carcinoma

Future Oncology, Ahead of Print.

Source: Future Oncology - October 4, 2020 Category: Cancer & Oncology Authors: Martina Spisarov á Bohuslav Melichar Denisa Vit ásková Hana Študentová Source Type: research